ArticleThe Lancet regional health. Western Pacific2026
Priority assessment of antimicrobial-resistant pathogens in the Republic of Korea: a multicriteria decision analysis.
Article in The Lancet regional health. Western Pacific, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Priority assessment of antimicrobial-resistant pathogens is essential for resource allocation and national risk management. This study aims to establish a priority list of antimicrobial-resistant pathogens to strengthen the national response to antimicrobial resistance (AMR) in the Republic of Korea (ROK). Methods: Antimicrobial-resistant pathogens were ranked throughout a multicriteria decision analysis using a preference-based survey based on PAPRIKA (Potentially All Pairwise Rankings of all possible Alternatives) method. This process involved identifying relevant criteria to evaluate pathogen priority and collecting data on disease burden for each antimicrobial-resistant pathogen. Findings: A literature review was conducted to develop a candidate list of antimicrobial-resistant pathogens (n = 56) and risk assessment criteria (n = 14). Seventeen pathogens and eight criteria were selected via a Delphi survey of experts (n = 31). Incidence, case fatality, five-year trend of AMR, and nonfatal health burden was set as quantitative indicators, while transmissibility, preventability, treatability, and antibiotic development pipeline were qualitative indicators. The pathogens were ranked using 56 expert responses from the PAPRIKA survey, and categorized them into three priority groups: emergency response, preferred management, and monitoring. The emergency response group included carbapenem-resistant (CR) Interpretation: This priority list represents the first comprehensive assessment of AMR pathogens of greatest concern to the Korean healthcare system. Our findings may inform country-specific policy decisions, particularly regarding infection prevention and control and AMR research and development. Funding: This work was supported by a fund (Grant No. 2024ER220500) provided by the Korea National Institute of Health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.